中证投服中心公开提名独董“又一单”

Core Viewpoint - The China Securities Investor Services Center has nominated an independent director candidate, Du Jian, for the board of Shangfeng Cement, marking the second public nomination of independent directors following the successful nomination for First Pharmaceutical in June 2024. This initiative aligns with the State Council's opinions on reforming the independent director system and aims to enhance the nomination process for independent directors, thereby protecting the rights of minority shareholders [1][2]. Group 1: Policy and Regulatory Framework - The State Council's opinions released in April 2023 encourage investor protection institutions to publicly solicit shareholder rights for nominating independent directors, aiming to improve the independent director selection system [1][3]. - The China Securities Regulatory Commission's newly released Independent Director Management Measures allow investor protection institutions to publicly request shareholders to delegate their rights to nominate independent directors, thus providing a clear direction for enhancing minority shareholder participation in corporate governance [2][3]. Group 2: Implementation and Impact - The nomination of Du Jian, who has extensive compliance management experience and a strong academic background, reflects a shift towards a more market-oriented and diversified approach in the independent director nomination process [3][4]. - The public solicitation of voting rights by the China Securities Investor Services Center aims to enhance the participation and influence of minority shareholders in corporate governance, ultimately leading to improved company governance structures and long-term value growth [4].